Who owns SPYGLASS PHARMA INC?
- Ticker: SGP
- CUSIP Number: 85220g109
Tip: Access positions for across all investors
Analyze quarterly positions in Spyglass Pharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Spyglass Pharma stock
Who bought or sold SPYGLASS PHARMA INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| RA Capital Management | 8.0M | $179M | 0% | Jun 2026 |
|
| NEA Management Company | 7.4M | $165M | 0% | Jun 2026 |
|
| Sands Capital Ventures | 2.5M | $56M | 0% | Jun 2026 |
|
| Samsara BioCapital | 2.1M | $47M | 0% | Jun 2026 |
|
| BlackRock | 712k | $16M | 392% | Jun 2026 |
|
| T. Rowe Price Associates | 704k | $18M | 100% | Mar 2026 |
|
| Vestal Point Capital | 670k | $15M | 0% | Jun 2026 |
|
| Jpmorgan Chase & Co | 630k | $14M | 100% | Jun 2026 |
|
| Deerfield Management Company | 550k | $12M | 0% | Jun 2026 |
|
| Millennium Management | 507k | $11M | 8% | Jun 2026 |
|
| Standard Life Aberdeen | 493k | $11M | 124% | Jun 2026 |
|
| Vanguard Capital Management | 434k | $9.7M | 0% | Jun 2026 |
|
| Geode Capital Management | 277k | $6.2M | 119% | Jun 2026 |
|
| Franklin Resources | 233k | $5.2M | -22% | Jun 2026 |
|
| Affinity Asset Advisors | 132k | $2.9M | -47% | Jun 2026 |
|
| Charles Schwab Investment Management | 86k | $1.9M | 44% | Jun 2026 |
|
| Sixth Street Partners Management Company | 86k | $1.9M | 100% | Jun 2026 |
|
| Northern Trust | 83k | $1.8M | 295% | Jun 2026 |
|
| Vanguard Portfolio Management | 76k | $1.7M | 1960% | Jun 2026 |
|
| Vanguard Fiduciary Trust | 69k | $1.5M | 15% | Jun 2026 |
|
| Alyeska Investment Group | 57k | $1.3M | 0% | Jun 2026 |
|
| TD Asset Management | 48k | $1.1M | 0% | Jun 2026 |
|
| Ameriprise Financial | 46k | $1.0M | 3% | Jun 2026 |
|
| ALPS Advisors | 34k | $755k | 100% | Jun 2026 |
|
| Bank of New York Mellon | 24k | $533k | 100% | Jun 2026 |
|
| Virtus Investment Advisers | 18k | $395k | 100% | Jun 2026 |
|
| State Street Corporation | 17k | $447k | 100% | Mar 2026 |
|
| Nuveen | 15k | $326k | 100% | Jun 2026 |
|
| Manufacturers Life Insurance Company | 13k | $278k | 5% | Jun 2026 |
|
| Rhumbline Advisers | 12k | $264k | 100% | Jun 2026 |
|
| Bank of America Corporation | 11k | $250k | -60% | Jun 2026 |
|
| Deutsche Bank Aktiengesellschaft | 11k | $244k | 100% | Jun 2026 |
|
| Wells Fargo & Company | 9.9k | $219k | 100% | Jun 2026 |
|
| UBS Group | 7.9k | $177k | 1646% | Jun 2026 |
|
| MetLife Investment Advisors | 7.0k | $156k | 100% | Jun 2026 |
|
| New York State Common Retirement Fund | 5.4k | $120k | 100% | Jun 2026 |
|
| Mirae Asset Global Etfs Holdings | 5.1k | $114k | 100% | Jun 2026 |
|
| Vanguard Global Advisers | 4.6k | $103k | -6% | Jun 2026 |
|
| Morgan Stanley | 4.2k | $108k | 100% | Mar 2026 |
|
| Police & Firemen's Retirement System of New Jersey | 3.3k | $73k | 100% | Jun 2026 |
|
| Barclays | 2.2k | $49k | 1478% | Jun 2026 |
|
| OTR - Nominee Name for The State Teachers Retirement Board of Ohio | 2.2k | $49k | 100% | Jun 2026 |
|
| Bnp Paribas Arbitrage, Snc | 2.0k | $45k | 100% | Jun 2026 |
|
| FMR | 1.5k | $33k | 100% | Jun 2026 |
|
| Legal & General Group | 1.1k | $24k | 100% | Jun 2026 |
|
| Summit Investment Advisors | 1.0k | $22k | 100% | Jun 2026 |
|
| Russell Investments | 886.00 | $20k | 100% | Jun 2026 |
|
| Tower Research Capital | 750.00 | $17k | 100% | Jun 2026 |
|
| Royal Bank of Canada | 589.00 | $13k | 593% | Jun 2026 |
|
| California State Teachers Retirement System | 153.00 | $3.4k | 100% | Jun 2026 |
|
| Sterling Capital Management | 97.00 | $2.2k | 100% | Jun 2026 |
|
| Caitong International Asset Management | 10.00 | $223.000000 | 100% | Jun 2026 |
|
Who sold out of Spyglass Pharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| First Light Asset Management | Mar 2026 | 375k | $9.7M |
| Monashee Investment Management | Mar 2026 | 95k | $2.5M |
| Marshall Wace | Mar 2026 | 29k | $760k |
| Goldman Sachs Group | Mar 2026 | 19k | $500k |
| Squarepoint Ops | Mar 2026 | 7.8k | $202k |